Fig. 1: Kaplan–Meier analysis for prognosis of patients with TILs categories and Miller-Payne 4/5.

a Disease-free survival in TNBC with Miller-Payne 4/5. b Overall survival in TNBC with Miller-Payne 4/5. c Disease-free survival in TNBC with TILs categories. d Overall survival in TNBC with TILs categories. Miller-Payne 4 subgroup analysis for disease-free survival (e) and overall survival (f) in TNBC patients with TILs categories. Miller-Payne 5 subgroup analysis for disease-free survival (g) and overall survival (h) in TNBC patients with TILs categories. p-value < 0.05 represented significance based on log-rank test. TILs tumor-infiltrating lymphocytes, TNBC triple-negative breast cancer.